Targeting the KMT2D-driven Enhancer-Immune-Metabolic axis in HNSCC: Reconciling the paradox for precision therapy.
- DOI
- 10.1016/j.bbcan.2026.189642
- Published
- 2026 Sep
- Container
- Biochimica et biophysica acta. Reviews on cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbcan.2026.189642,
title = {Targeting the KMT2D-driven Enhancer-Immune-Metabolic axis in HNSCC: Reconciling the paradox for precision therapy.},
author = {Wang K and Lu H and Deng N and Tao Y and Yang X and Yuan M and Gao L and Jiang S and Shang W and Deng J and Wang L},
year = {2026},
journal = {Biochimica et biophysica acta. Reviews on cancer},
doi = {10.1016/j.bbcan.2026.189642},
url = {https://doi.org/10.1016/j.bbcan.2026.189642}
}RIS
TY - JOUR TI - Targeting the KMT2D-driven Enhancer-Immune-Metabolic axis in HNSCC: Reconciling the paradox for precision therapy. AU - Wang K AU - Lu H AU - Deng N AU - Tao Y AU - Yang X AU - Yuan M AU - Gao L AU - Jiang S AU - Shang W AU - Deng J AU - Wang L PY - 2026 JO - Biochimica et biophysica acta. Reviews on cancer DO - 10.1016/j.bbcan.2026.189642 UR - https://doi.org/10.1016/j.bbcan.2026.189642 ER -
APA
K, W., H, L., N, D., Y, T., X, Y., M, Y., L, G., S, J., W, S., J, D., & L, W. (2026). Targeting the KMT2D-driven Enhancer-Immune-Metabolic axis in HNSCC: Reconciling the paradox for precision therapy.. Biochimica et biophysica acta. Reviews on cancer. https://doi.org/10.1016/j.bbcan.2026.189642
Source records
- pubmed · retrieved 2026-09-26T05:41:27.565Z